LDLR and atherosclerosis: To this end, we specifically assessed the role of hematopoietic PI3Kδ on immune mechanisms affecting plaque progression in atherosclerosis-prone LDL receptor–deficient (B6.129S7-Ldlrtm1Her/J; Ldlr–/–) mice (27).